Use of Rituximab in Autoimmune Hemolytic Anemia Associated with Non-Hodgkin Lymphomas

Nabhan, C., & Kay, N. E. (2011). The Emerging Role of Ofatumumab in the Treatment of Chronic Lymphocytic Leukemia. Clinical Medicine Insights: Oncology, (), 45-53. https://doi.org/10.4137/CMO.S4087
Rossi, M., Laginestra, M. A., Gazzola, A., Sapienza, M. R., Pileri, S. A., & Piccaluga, P. P. (2012). Molecular Profiling of Aggressive Lymphomas. Advances in Hematology, 2012(), 258-266. https://doi.org/10.1155/2012/464680
Shinohara, K. (2017). Visible effect of immunomodulatory drugs on rib tumor in multiple myeloma. International Journal of Case Reports and Images (IJCRI), 8(1), a20+89-91. https://doi.org/10.5348/ijcri-201702-CL-10112
林毓棼（2012）。Study on the Roles of Hypoxia-related Adrenomedullin (AM) in Acute Myeloid Leukemia (AML)〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2012.00090
Hwang, Y. Y., & Liang, R. H. S. (2010). An Update in Management of Noncutaneous T-Cell Lymphomas. Advances in Hematology, 2010(), 162-167. https://doi.org/10.1155/2010/424786